Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 29, 2009


Todd Johnson has been named senior vice president of marketing and operations at Accelrys.

Johnson was most recently the firm's interim president and CEO after the resignation of Mark Emkjer in January. He held that post through June 15, when the company tapped Max Carnecchia as its new CEO.

According to an SEC filing, Johnson will be employed on a part-time basis with an annual base salary of $111,000 and is eligible for a bonus.

Johnson was previously senior vice president of strategy and corporate development at MDS Pharma Services. He has also held positions as a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company.

Prior to that he was CEO of Tangerine Technologies and was a cancer researcher at the Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.